108 filings
ARS
2023 FY
VIRI
Virios Therapeutics Inc
29 Apr 24
Annual report to shareholders
5:26pm
DEF 14A
VIRI
Virios Therapeutics Inc
Definitive proxy
25 Apr 24
4:33pm
8-K
VIRI
Virios Therapeutics Inc
6 Mar 24
Submission of Matters to a Vote of Security Holders
4:30pm
10-K
2023 FY
VIRI
Virios Therapeutics Inc
Annual report
1 Mar 24
9:10am
8-K
b061o7rwso 2je
29 Feb 24
Virios Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results
9:25am
DEFA14A
rbxwds
27 Feb 24
Additional proxy soliciting materials
4:21pm
8-K
z1e0gagtnpu9jc
27 Feb 24
Departure of Directors or Certain Officers
4:15pm
8-K
g18vgeo
3 Jan 24
Regulation FD Disclosure
7:05am
8-K
5gs2svuow
13 Nov 23
Virios Therapeutics Announces Third Quarter 2023 Financial Results and Provides Corporate Update
7:20am
8-K
gz5g7s90 3wfcy6n
7 Nov 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
7:29am
8-K
y8g qeq62hkb1193z
2 Nov 23
Regulation FD Disclosure
7:05am
8-K
1pzpu 4f1xnne3ri
18 Sep 23
Virios Therapeutics Announces Termination of At-The-Market Sales Agreement
7:16am
8-K
yacfbar9hqhcwl3
10 Aug 23
Virios Therapeutics Announces Second Quarter 2023 Financial Results and Provides Corporate Update
7:15am
8-K
0ad71ge
9 Aug 23
Virios Therapeutics Announces Plans to Advance Lead Candidate IMC-1 to Phase 3 Development as a New Treatment Option for Fibromyalgia
7:15am
8-K
qdoxiitz3f0z30nbkmp
17 Jul 23
Results of Operations and Financial Condition
7:15am